Skip to main content

Table 3 Influence of patient-related risk factors on surgial morbidity. Lymphatic fistulas are defined as persistent secretion of lymphatic fluid for 21 days or more after LND. Wound infection was assumed if any typical symptoms (e. g., redness, purulent discharge, abscess formation) were detected. Neurological complications were defined if symptoms like postoperative paraesthesia, or loss of motor function were detected. Severe bleeding was defined as bleeding that needs to be surgically revised

From: Morbidity and oncologic outcome after saphenous vein-sparing inguinal lymphadenectomy in melanoma patients

  

Nicotine abuse

Diabetes mellitus

Arterial hypertonia

BMI >30

  

Yes

No

p value

Yes

No

p value

Yes

No

p value

Yes

No

p value

Lympatic fistula

[%]

37.5

54.3

0.1477

66.7

49.0

0.3096

55.1

46.4

0.3752

65.4

45.6

0.0796

Wound infection

[%]

25.0

29.6

0.6592

22.2

29.2

0.6592

36.7

21.4

0.0833

42.3

24.1

0.0739

Severe bleeding

[%]

4.2

6.1

0.7188

11.1

5.2

0.4595

10.2

1.8

0.0605

57.7

5.0

0.6058

Neurological complications

[%]

0.0

2.4

0.4399

11.1

1.0

0.0335

2.0

1.8

0.9139

3.8

1.3

0.3980

Lymphedemaa

[%]

28.6

27.7

0.9378

28.6

27.8

0.9674

27.0

28.6

0.8744

36.4

25.0

0.3053

  1. aOnly patients with a complete 6-month follow-up after LND were considered